Exane Derivatives’s UBS Group UBS Stock Holding History

Exane Derivatives’s Portfolio UBS Stock Details UBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$360K	Sell	22,455 -21,925	-49%	-$384K	0.21%	118
2022 Q1	$871K	Sell	44,380 -268,874	-86%	-$5.09M	0.25%	109
2021 Q4	$5.64M	Sell	313,254 -1,333,733	-81%	-$23.5M	1.36%	11
2021 Q3	$26.4M	Buy	1,646,987 +460,858	+39%	+$7.46M	6.34%	1
2021 Q2	$17.7M	Buy	1,186,129 +976,648	+466%	+$15.4M	4.01%	2
2021 Q1	$3.25M	Sell	209,481 -189,428	-47%	-$2.91M	0.93%	23
2020 Q4	$5.65M	Sell	398,909 -415,488	-51%	-$5.5M	1.66%	8
2020 Q3	$9.09M	Sell	814,397 -325,611	-29%	-$3.9M	2.63%	7
2020 Q2	$13.1M	Buy	1,140,008 +575,452	+102%	+$5.93M	3.49%	2
2020 Q1	$5.29M	Sell	564,556 -2,089,838	-79%	-$24.1M	1.48%	14
2019 Q4	$34.7M	Sell	2,654,394 -1,829,861	-41%	-$21.8M	6.43%	1
2019 Q3	$51M	Buy	4,484,255 +678,377	+18%	+$7.64M	9.15%	1
2019 Q2	$45.2M	Buy	3,805,878 +2,886,544	+314%	+$35.4M	7.93%	1
2019 Q1	$11.2M	Buy	+919,334	New	+$11.6M	2.2%	7
2018 Q4	–	Sell	-2,275,073	Closed	-$30.9M	–	742
2018 Q3	$36.1M	Buy	2,275,073 +1,102,557	+94%	+$17.3M	6.77%	1
2018 Q2	$18.1M	Buy	+1,172,516	New	+$19.1M	3.02%	5
2018 Q1	–	Sell	-1,801,883	Closed	-$34.3M	–	660
2017 Q4	$33.1M	Sell	1,801,883 -2,191,863	-55%	-$38.1M	5.71%	2
2017 Q3	$68.1M	Buy	3,993,746 +3,505,876	+719%	+$60M	12.73%	1
2017 Q2	$8.27M	Buy	+487,870	New	+$7.93M	1.78%	8
2017 Q1	–	Sell	-813,750	Closed	-$13.1M	–	679
2016 Q4	$12.7M	Sell	813,750 -320,204	-28%	-$4.82M	2.51%	8
2016 Q3	$15.4M	Sell	1,133,954 -489,188	-30%	-$6.66M	2.31%	6
2016 Q2	$20.8M	Buy	+1,623,142	New	+$24.8M	3.44%	2
2016 Q1	–	Sell	-561,329	Closed	-$9.12M	–	616
2015 Q4	$11M	Buy	+561,329	New	+$11M	1.51%	28
2015 Q2	–	Sell	-943,837	Closed	-$19.7M	–	554
2015 Q1	$17.8M	Sell	943,837 -787,179	-45%	-$13.7M	1.96%	27
2014 Q4	$29.9M	Buy	+1,731,016	New	+$29.6M	4.14%	1

Other funds holding UBS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Zurich Cantonal Bank Zurich, Switzerland $46B AUM 27.59% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Exane Derivatives's UBS Position: Q2 2022 in Review

Exane Derivatives reduced its UBS Group (UBS) stake by 49% in Q2 2022, selling an estimated $384K and leaving 22,455 shares worth $360K. The position accounts for 0.21% of the portfolio, ranked #118.

Exane Derivatives first reported a position in UBS in Q4 2014 and has held it in 25 quarters since. The position peaked at $68.1M in Q3 2017. 368 funds tracked by Wall St. Rank hold UBS as of Q2 2022.

Exane Derivatives held 22,455 shares of UBS Group worth $360K as of Q2 2022.
Exane Derivatives sold 21,925 UBS Group shares in Q2 2022, an estimated $384K.
UBS Group made up 0.21% of Exane Derivatives's portfolio in Q2 2022, its #118 holding.
Exane Derivatives first reported a position in UBS Group in Q4 2014 and has held it in 25 quarters since.
Exane Derivatives's UBS Group position peaked at $68.1M in Q3 2017.
368 funds tracked by Wall St. Rank held UBS Group as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.